EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 339 filers reported holding EXELIXIS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,925 | +14.3% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $9,555 | -1.5% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $9,705 | +21.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $8,020 | +0.2% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $8,000 | -20.0% | 500 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $10,000 | -9.1% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $11,000 | +22.2% | 500 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $9,000 | -69.0% | 500 | -63.9% | 0.00% | -80.0% |
| Q3 2021 | $29,000 | +16.0% | 1,386 | 0.0% | 0.01% | +25.0% |
| Q2 2021 | $25,000 | -19.4% | 1,386 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $31,000 | +10.7% | 1,386 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $28,000 | -17.6% | 1,386 | 0.0% | 0.01% | -25.0% |
| Q3 2020 | $34,000 | +3.0% | 1,386 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $33,000 | +266.7% | 1,386 | +177.2% | 0.01% | +100.0% |
| Q1 2020 | $9,000 | 0.0% | 500 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $9,000 | 0.0% | 500 | 0.0% | 0.00% | -20.0% |
| Q3 2019 | $9,000 | -10.0% | 500 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $10,000 | -16.7% | 500 | 0.0% | 0.01% | -28.6% |
| Q1 2019 | $12,000 | +9.1% | 500 | 0.0% | 0.01% | +16.7% |
| Q2 2018 | $11,000 | – | 500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |